ICON Launches Electronic Informed Consent

April 27, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

ICON has announced Firecrest eConsent, an electronic informed consent solution that incorporates recommendations from the FDA¹s recent draft guidance on informed consent.

ICON has announced Firecrest eConsent, an electronic informed consent solution that incorporates recommendations from the FDA¹s recent draft guidance on informed consent.

The e-Consent solution is a component of ICON¹s new informatics hub designed to enhance the engagement of patient populations in the drug development process. The solution employs videos and visual aids to assist in the explanation of complex scientific concepts and medical terms found in trial protocols. 

Related Content:

News